3
Announcements
Trials
Browse
Landscape
Status
Recruiting
5
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
1
Hematologic Neoplasms
1
Cardiovascular Diseases
1
Interventions
Specimen Handling
76
Bevacizumab
66
Drug Therapy
64
Cisplatin
64
Carboplatin
63
Magnetic Resonance Spectroscopy
59
Radiotherapy
57
pembrolizumab
54
Gemcitabine
54
Cyclophosphamide
54
Capecitabine
51
Oxaliplatin
50
toripalimab
44
Paclitaxel
41
tislelizumab
40
Standard of Care
39
fludarabine
36
Fluorouracil
35
Injections
34
Biopsy
34
venetoclax
33
Blood Specimen Collection
31
Immune Checkpoint Inhibitors
30
anlotinib
29
Surgical Procedures, Operative
28
Nivolumab
28
Irinotecan
27
Docetaxel
27
Dexamethasone
27
Leucovorin
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Antineoplastic Agents
×
1 year
×
Clear all
NCT07621289
2026-06-02
EUCARTOXSCORES
University Hospital, Caen
Not yet recruiting
10,000 enrolled